PHILADELPHIA — Differences in the utilization of intensive care services may be one potential explanation for improved outcomes after major surgery in the U.S. versus other nations, according to a commentary published in JAMA Surgery by researchers from the Perelman School of Medicine at the University of Pennsylvania.
The researchers comment on two recent studies from Europe that document international variations in surgical outcomes, along with suggestive evidence as to the causes of these variations.
The first study, published by researchers in the U.K., showed that of half the high-risk surgical patients in the study who died never went to an intensive care unit (ICU). Instead of being admitted directly to the intensive care unit after surgery, they received treatment on a standard surgical ward. The second study, published in 2012 by a group of researchers from 28 European countries, found that among surgical patients who died during hospitalization, 75 percent were never treated in an ICU.
In their commentary, corresponding author Mark D. Neuman, MD, MSc, assistant professor of Anesthesiology and Critical Care and co-author Lee A. Fleisher, MD, chair of the Department of Anesthesiology and Critical Care, note past evidence indicating more aggressive use of critical care services in the U.S. compared to other nations. In one study of American and British patients who died after major surgical procedures, approximately 8.5 percent of the U.K. patients were admitted to an ICU at some point in their hospital stay, compared to 61 percent in the U.S.
“While it’s too early to make definitive claims regarding the degree to which ICU care might produce survival benefits for surgical patients, the evidence we have to date clearly warrants further study,” says Neuman.
The authors add that the national consensus to limit spending on health care services while also preserving health care quality creates a need for a better understanding of how pre- and post-surgical care – as well as the care delivered during surgical procedures themselves – contributes to surgical outcomes in the United States.
Citing these factors, Neuman and Fleisher call for more research on 1) how key postoperative outcomes, such as mortality, differ between the United States and other developed nations; 2) how variations in the setting and quality of postoperative care contribute to such differences; and 3) what financial and social costs are incurred by differing approaches to ICU utilization for high-risk surgical patients.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.